From Chatbot to Co-Scientist: How AI Discovered a CRISPR-like Enzyme
When we think of scientific breakthroughs, we usually picture researchers in white coats spending years meticulously testing hypotheses in a lab. But the...

When we think of scientific breakthroughs, we usually picture researchers in white coats spending years meticulously testing hypotheses in a lab. But the future of discovery might look more like a server farm quietly humming through the night.
Anthropic, the AI company behind the Claude model, recently announced a milestone that bridges the gap between artificial intelligence and biology. In the first major result from their newly established "wet lab"—a traditional laboratory where biological matter is tested physically—Claude autonomously identified a novel enzyme system. The company believes this discovery could be as significant as CRISPR, the famous genetic machinery that revolutionized modern biology by allowing precise DNA editing.
The mechanics behind this breakthrough highlight a profound shift in how AI operates. Instead of merely answering questions or summarizing research papers, Claude acted as an autonomous, tireless research team. After receiving a single initial prompt from human scientists, an army of nearly 950 Claude AI agents was deployed.
For 21 straight hours, these agents sifted through a massive database of DNA sequences, processing a staggering 210 million tokens of information. Eventually, one of these agents spotted an unusual, repeating pattern that human eyes might have easily missed. Human involvement was strictly limited to that first command and the subsequent physical lab work required to verify the digital findings.
This event is more than just a successful experiment for a company reportedly preparing for an initial public offering; it represents a paradigm shift in technology. By integrating Claude directly into a scientific environment, Anthropic is demonstrating that its models have utility far beyond enterprise software and conversational chatbots.
Artificial intelligence is graduating from a sophisticated tool to a genuine co-discoverer in the scientific method. As AI models begin to autonomously navigate the complex code of life, they promise to accelerate biotechnology and medicine in ways we can scarcely imagine. Yet, it also leaves us with a profound realization: in the scientific endeavors of tomorrow, humanity's greatest contribution might simply be knowing which questions to ask the machine.
Key Points
- Claude autonomously discovered a new enzyme system that rivals the gene-editing tool CRISPR in potential significance.
- The discovery was made by nearly 950 AI agents analyzing 210 million tokens of DNA data over 21 hours.
- Human researchers only provided the starting prompt and conducted the physical verification in the lab.
- The achievement highlights AI's transition from a passive computational tool to an autonomous scientific researcher.
Why It Matters
This breakthrough demonstrates that AI can autonomously navigate complex biological data to make novel discoveries, potentially accelerating medical and genetic research while redefining the role of human scientists.
Sources:
- Anthropic’s biolab made a discovery it’s comparing to Crispr — The Verge - AI
更多专栏

Your Next Coworker is a Blob That Orders Burritos
For decades, enterprise software has been synonymous with sterile dashboards, en...

The Midnight Bill: Why AI Agents Demand Hard Budget Caps
The dream of artificial intelligence is to have a tireless digital assistant wor...

Beyond Transformers: How Mamba is Rewriting the Rules of AI Memory
Think about how a human reads a sprawling, thousand-page fantasy series. You don...